No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr19:39685000-39690000 |
Enhancers |
A549 |
lung
|
2 |
chr19:39686800-39693200 |
Weak transcription |
Gastric |
stomach
|
3 |
chr19:39687800-39690600 |
Weak transcription |
Right Atrium |
heart
|
4 |
chr19:39688000-39691200 |
Enhancers |
Pancreas |
Pancrea
|
5 |
chr19:39688800-39690000 |
Bivalent Enhancer |
Fetal Adrenal Gland |
Adrenal Gland
|
6 |
chr19:39688800-39690800 |
Enhancers |
Placenta |
Placenta
|
7 |
chr19:39689200-39691400 |
Weak transcription |
Hela-S3 |
cervix
|
8 |
chr19:39689400-39690000 |
Bivalent Enhancer |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
9 |
chr19:39689400-39690200 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
10 |
chr19:39689400-39690200 |
Enhancers |
Ovary |
ovary
|
11 |
chr19:39689400-39690800 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
12 |
chr19:39689600-39690000 |
Flanking Active TSS |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
13 |
chr19:39689600-39690000 |
Enhancers |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
14 |
chr19:39689600-39690000 |
Bivalent Enhancer |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
15 |
chr19:39689600-39690000 |
Bivalent Enhancer |
HUES6 Cell Line |
embryonic stem cell
|
16 |
chr19:39689600-39690000 |
Flanking Bivalent TSS/Enh |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
17 |
chr19:39689600-39690000 |
Bivalent Enhancer |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
18 |
chr19:39689600-39690000 |
Bivalent/Poised TSS |
Brain Cingulate Gyrus |
brain
|
19 |
chr19:39689600-39690000 |
Bivalent/Poised TSS |
Brain Substantia Nigra |
brain
|
20 |
chr19:39689600-39690000 |
Transcr. at gene 5' and 3' |
Esophagus |
oesophagus
|
21 |
chr19:39689600-39690000 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
22 |
chr19:39689600-39690000 |
Flanking Bivalent TSS/Enh |
HepG2 |
liver
|
23 |
chr19:39689600-39690000 |
Bivalent Enhancer |
NHLF |
lung
|
24 |
chr19:39689600-39690200 |
Bivalent Enhancer |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
25 |
chr19:39689600-39690200 |
Bivalent/Poised TSS |
Osteobl |
bone
|
26 |
chr19:39689800-39690000 |
Bivalent Enhancer |
ES-I3 Cell Line |
embryonic stem cell
|
27 |
chr19:39689800-39690000 |
Bivalent Enhancer |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
28 |
chr19:39689800-39690000 |
Flanking Bivalent TSS/Enh |
Muscle Satellite Cultured Cells |
--
|
29 |
chr19:39689800-39690000 |
Bivalent Enhancer |
Cortex derived primary cultured neurospheres |
brain
|
30 |
chr19:39689800-39690000 |
Bivalent Enhancer |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
31 |
chr19:39689800-39690000 |
Bivalent Enhancer |
Adipose Nuclei |
Adipose
|
32 |
chr19:39689800-39690000 |
Bivalent/Poised TSS |
Brain Hippocampus Middle |
brain
|
33 |
chr19:39689800-39690000 |
Bivalent Enhancer |
Fetal Intestine Small |
intestine
|
34 |
chr19:39689800-39690000 |
Bivalent/Poised TSS |
Fetal Lung |
lung
|
35 |
chr19:39689800-39690000 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
36 |
chr19:39689800-39690000 |
Flanking Bivalent TSS/Enh |
Skeletal Muscle Male |
skeletal muscle
|
37 |
chr19:39689800-39690000 |
Enhancers |
K562 |
blood
|
38 |
chr19:39689800-39690200 |
Flanking Bivalent TSS/Enh |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
39 |
chr19:39689800-39690200 |
Enhancers |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|